We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medcura Receives Breakthrough Device Designation for LifeGel to Manage Surgical Bleeding
The item has been added to your shopping cart.
Medcura Receives Breakthrough Device Designation for LifeGel to Manage Surgical Bleeding
Maryland-based Medcura announced that the FDA has granted the company’s LifeGel absorbable surgical hemostatic gel Breakthrough Device designation as a hemostatic agent to control bleeding during surgical procedures.